Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$3.2 million.

  • Usana Health Sciences' Cash from Investing Activities fell 3678.36% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$216.4 million, marking a year-over-year decrease of 131660.99%. This contributed to the annual value of -$213.1 million for FY2024, which is 167945.72% down from last year.
  • Usana Health Sciences' Cash from Investing Activities amounted to -$3.2 million in Q3 2025, which was down 3678.36% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Cash from Investing Activities registered a high of $179000.0 during Q3 2023, and its lowest value of -$205.1 million during Q4 2024.
  • Over the past 5 years, Usana Health Sciences' median Cash from Investing Activities value was -$3.3 million (recorded in 2022), while the average stood at -$14.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 10480.8% in 2023, then crashed by 270166.62% in 2024.
  • Over the past 5 years, Usana Health Sciences' Cash from Investing Activities (Quarter) stood at -$3.1 million in 2021, then fell by 6.28% to -$3.3 million in 2022, then tumbled by 123.1% to -$7.3 million in 2023, then crashed by 2701.67% to -$205.1 million in 2024, then skyrocketed by 98.44% to -$3.2 million in 2025.
  • Its Cash from Investing Activities was -$3.2 million in Q3 2025, compared to -$4.2 million in Q2 2025 and -$3.9 million in Q1 2025.